University Heights, OH (PRWEB) May 03, 2012
Australian doctors may have found a way to prevent unborn babies from developing cerebral palsy according to a April 3rd press relaease (1) from Monash Medical Centre. In the study pregnant women whose babies are not developing normally will be given melatonin that doctors believe will stop their babies from suffering brain damage in the womb. Maximizing natural melatonin by controlling light is a step in the right direction. The use of LowBlueLight glasses for a few hours before bedtime can increase melatonin production to the 11 or 12 hours known to be possible.
For a significantly growth-restricted baby, the placenta does not provide sufficient oxygen and nutrients for the developing brain. Scientists at Monash have established that the brain injury is caused by oxidative stress, in which excess chemicals called free radicals damage normal tissues.
A number of studies with sheep have established that adding melatonin to drinking water helps to protect the white matter in the brain of the fetus from damage by the free radicals. In these experiments the cord was constricted to reduce blood flow to the fetus. Related studies in humans where a stroke has interrupted the supply of oxygen to the brain have shown that melatonin helps to avoid damage to brain cells.
So far the main use for the orange glasses provided on the website LowBlueLights.com has been to help people achieve better sleep. Thousands have found they really work for this purpose. The reason is that wearing the glasses a few hour before bedtime allows melatonin to start flowing so plenty is there at bedtime. This makes it easy to fall and stay asleep. Pregnant women frequently have trouble sleeping. This new finding that melatonin may help avoid birth defects provides another reason to use the glasses.
For information contact Dr. Richard Hansler at John Carroll University 216 3971657 or email rhansler(at)jcu(dot)edu.
(1) Breakthrough treatment raises hopes of fighting cerebral palsy in the womb
(2)Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion.